Literature DB >> 34581931

MiR-361-5p promotes oxygen-glucose deprivation/re-oxygenation induced neuronal injury by negatively regulating SQSTM1 in vitro.

Tao Zeng1, Sai Zhang2, Yan He2, Zhenxing Liu2, Qiusheng Cheng2.   

Abstract

It has been reported that microRNAs (miRNAs) play essential roles in cerebral ischemia and reperfusion (I/R) injury. This study aimed to explore the role of miR-361-5p in oxygen-glucose deprivation/re-oxygenation-induced neuronal injury in vitro. Cerebral I/R injury cell model was established by using PC12 cells exposed to oxygen-glucose deprivation/re-oxygenation (OGD/R). The expression of miR-361-5p and SQSTM1 was evaluated by qRT-PCR or western blot. Neuronal apoptosis was detected by flow cytometry, and cell viability was assessed by CCK-8 assay. The effects of miR-361-5p on the release of LDH and the levels of MDA, SOD, and GSH-Px were investigated by respective detection kits. Dual-luciferase reporter assay and RIP assay were performed to determine the interaction between miR-361-5p and SQSTM1. Rescue experiments were performed to evaluate the function of miR-361-5p and SQSTM1. MiR-361-5p was significantly upregulated, and SQSTM1 was significantly downregulated in OGD/R-stimulated PC12 cells. MiR-361-5p could directly interact with SQSTM1 and negatively regulated it. Inhibition of miR-361-5p efficiently inhibited OGD/R-induced apoptosis and attenuated OGD/R-induced growth defect in PC12 cells. In addition, SQSTM1 overexpression partially attenuates the apoptosis and promoted the viability of OGD/R-treated PC12 cells, which were aggravated by miR-361-5p mimics. Our study demonstrated that miR-361-5p promotes OGD/R-induced neuronal injury via regulating SQSTM1 in PC12 cells.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; MiR-361-5p; Oxygen–glucose deprivation/re-oxygenation; SQSTM1

Mesh:

Substances:

Year:  2021        PMID: 34581931     DOI: 10.1007/s11011-021-00845-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  27 in total

Review 1.  Biochemistry of oxidative stress.

Authors:  B Halliwell
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 2.  Stroke.

Authors:  Graeme J Hankey
Journal:  Lancet       Date:  2016-09-13       Impact factor: 79.321

Review 3.  An overview of microRNAs.

Authors:  Scott M Hammond
Journal:  Adv Drug Deliv Rev       Date:  2015-05-12       Impact factor: 15.470

4.  Inhibition of MiRNA-125b Decreases Cerebral Ischemia/Reperfusion Injury by Targeting CK2α/NADPH Oxidase Signaling.

Authors:  Yong Liang; Jing Xu; Yu Wang; Jia-Yu Tang; Song-Lin Yang; Hong-Guang Xiang; Shi-Xing Wu; Xiao-Juan Li
Journal:  Cell Physiol Biochem       Date:  2018-02-28

5.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

Review 6.  microRNA-140: A miRNA with diverse roles in human diseases.

Authors:  Soudeh Ghafouri-Fard; Zahra Bahroudi; Hamed Shoorei; Atefe Abak; Maliheh Ahin; Mohammad Taheri
Journal:  Biomed Pharmacother       Date:  2021-02-01       Impact factor: 6.529

7.  Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction.

Authors:  Qi He; Zhenyu Li; Yueting Wang; Yanghao Hou; Lingyu Li; Jing Zhao
Journal:  Int Immunopharmacol       Date:  2017-07-03       Impact factor: 4.932

8.  CircHIPK3 aggravates myocardial ischemia-reperfusion injury by binding to miRNA-124-3p.

Authors:  M Bai; C-L Pan; G-X Jiang; Y-M Zhang; Z Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-11       Impact factor: 3.507

9.  Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro.

Authors:  Zhaohui Chai; Jiangbiao Gong; Peidong Zheng; Jiesheng Zheng
Journal:  Biol Res       Date:  2020-04-20       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.